ksg 504 has been researched along with cholecystokinin in 1 studies
| Studies (ksg 504) | Trials (ksg 504) | Recent Studies (post-2010) (ksg 504) | Studies (cholecystokinin) | Trials (cholecystokinin) | Recent Studies (post-2010) (cholecystokinin) |
|---|---|---|---|---|---|
| 13 | 0 | 0 | 10,914 | 466 | 1,074 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moriyoshi, Y; Shiratori, K; Takeuchi, T; Watanabe, S | 1 |
1 other study(ies) available for ksg 504 and cholecystokinin
| Article | Year |
|---|---|
A new CCK-A antagonist, KSG-504, administered intraduodenally, inhibits pancreatic secretion in rats.
Topics: Animals; Caseins; Cholecystokinin; Duodenum; Male; Molecular Structure; Naphthalenes; Pancreas; Pentanoic Acids; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 1994 |